11:51 AM EST - Resverlogix Corp. : Announced it is supporting a satellite symposium on Saturday, August 25, at the European Society of Cardiology Congress 2018 in Munich, Germany, titled: LDL-c: Done Deal, Next Epigenetics? Resverlogix Corp.
shares T.RVX are trading up $0.10 at $3.08.
